Ignite Creation Date:
2024-05-05 @ 7:18 PM
Last Modification Date:
2024-10-26 @ 9:46 AM
Study NCT ID:
NCT00644345
Status:
UNKNOWN
Last Update Posted:
2008-03-26
First Post:
2008-03-23
Brief Title:
T-Wave Alternans TWA Reproducibility in CAD Patients
Sponsor:
Assaf-Harofeh Medical Center
Organization:
Assaf-Harofeh Medical Center
Study Overview
Official Title:
Reproducibility of T Wave Alternans Testing in Patients With Ischemic Heart Disease
Status:
UNKNOWN
Status Verified Date:
2008-03
Last Known Status:
NOT_YET_RECRUITING
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Microvolt T-Wave Alternans MTWA is a relatively new non-invasive method for identifying patients at increased risk of sudden death from ventricular arrhythmias MTWA can be measured during a routine exercise test during pharmacologic stress or during cardiac pacing Its clinical performance compares favorably with that of other non-invasive risk stratifiers and invasive electophysiologic studies The purpose of the present study is to define the reproducibility of MTWA testing
Detailed Description:
The study will be performed in the Cardiac Rehabilitation Center at Assaf Harofeh Medical Center Patients with coronary artery disease will be eligible to enroll
Patient will undergo an exercise test on a stationary bicycle TWA will be measured at heart rate of 105 and 115 BPM The test will be repeated one week later in the same fashion The patient will continue follow-up in the rehabilitation center as dictated by the rehabilitation program Patients will be kept on their regular medications and there will be no change of the medications from the first TWA measurement to the second
Patient will undergo an exercise test on a stationary bicycle TWA will be measured at heart rate of 105 and 115 BPM The test will be repeated one week later in the same fashion The patient will continue follow-up in the rehabilitation center as dictated by the rehabilitation program Patients will be kept on their regular medications and there will be no change of the medications from the first TWA measurement to the second
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None